Jeffrey Cornell, M.S., joined Statistics Collaborative, Inc. (SCI) in 2005. He is a member of the Society for Clinical Trials, the DC SAS User’s Group, and the Washington Statistical Society.
At SCI, Mr. Cornell manages multiple cardiovascular and oncology studies. He has assisted in developing data analysis plans for studies evaluating coronary artery bypass surgery and a novel treatment for major depression. In addition, he has co-developed table shells for multiple cardiovascular studies.
With over 18 years of SAS programming experience, Mr. Cornell has prepared tabular and graphical presentations for clinical trials in disease areas such as melanoma, multiple myeloma, lung, prostate, and kidney cancer, macular degeneration, ischemic heart disease, and diabetes, among others. He has performed randomization audits in a range of clinical trial settings, including retinal vein occlusion, age-related macular degeneration, diabetic macular edema, and isolated systolic hypertension. He prepares and audits CDISC-compliant ADaM datasets and documentation. He maintains MedDRA Preferred Term and SMQ datasets and documentation. As the SAS Macro Administrator, he develops, validates, and maintains company-wide SAS macros that improve project efficiency and data quality. Mr. Cornell also serves as a mentor and resource to SCI’s programmers, sharing best practices and examples to develop programming expertise throughout the company.
He received his B.S. in Mathematics from Michigan State University (1994) and his M.S. in Biology with a concentration in Environmental Science and Public Policy from George Mason University (2001).
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.